Schizoaffective Disorders Completed Phase 2 Trials for GTS-21 (DB05708)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01400477Nicotinic Receptors and SchizophreniaTreatment